Hub-Based Engagement Navigator to Reduce CSC Disengagement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project will co-create a hub-based Engagement Navigator Service (ENS) with CSC staff, participants, and families using participatory research methods within a learning health system. It will test feasibility and acceptability across three CSC programs and refine the service based on feedback. A mixed-methods evaluation using a hybrid type I open cohort stepped-wedge design will assess feasibility, acceptability, and whether ENS improves engagement and reduces disengagement compared with usual care. The intervention includes referral management, specialized engagement training, unbiased support during relationship challenges with CSC, re-engagement efforts, and continued contact with those who choose not to participate in treatment. The study targets youths and young adults with first-episode psychosis who are currently served by CSC programs.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients receiving services at Coordinated Specialty Care programs for the treatment of early episode psychosis
* Age 13-35

Exclusion Criteria:

* Do not meet inclusion criteria

Where it's running

• University of Maryland Baltimore
  Baltimore, Maryland, United States Recruiting

Study contacts

• Study coordinator: Melanie Bennett
• Email: mbennett@som.umaryland.edu
• Phone: 4107060892

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Time-restricted eating to help energy and fatigue in prostate or metastatic breast cancer

  This study tests whether eating all daily calories within a fixed window can improve energy and reduce frailty for adults with certain cancers who have fatigue.

  Recruiting Phase 2 University of Maryland, Baltimore · Baltimore, Maryland · NCT07826871

• Adaptive Chemotherapy for PD-L1 High Resectable NSCLC: A Chemo-PHREE Trial

  This study tests cemiplimab in adults with resectable non-small cell lung cancer to see if surgery can be pursued without preceding chemotherapy for some patients.

  Recruiting Phase 2 University of Maryland, Baltimore · Indianapolis, Indiana and 4 other locations · NCT07746388

• Virtual reality options to help with VOC pain in adults with SCD

  This study tests whether headset-based virtual reality can help reduce pain for adults with sickle cell disease during vaso-occlusive crises treated in an infusion center.

  Recruiting University of Maryland, Baltimore · Baltimore, Maryland · NCT07674277

• Gut permeability and microbiome in preterm infants

  This study tests a dual sugar probe test to measure gut permeability in very preterm babies to understand their risk for serious gut disease.

  Recruiting Phase 1 University of Maryland, Baltimore · Baltimore, Maryland · NCT07667049

• Recovery after mild traumatic brain injury in older adults

  This project will follow people 65 and older who had a mild TBI to see how their thinking, physical abilities, mood, and sleep change over the year after injury.

  Recruiting University of Maryland, Baltimore · Baltimore, Maryland · NCT07569354

• Biopsy-based test to compare wedge resection vs. radial incision for benign tracheal narrowing

  This study tests two airway-opening techniques in people with benign tracheal stenosis to see how their airway tissue changes after treatment.

  Recruiting University of Maryland, Baltimore · Baltimore, Maryland · NCT07463742

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.